Open access
Aug 2026
A new HIV-1 latency reversing agent activating HIV-Tat
D10 is the first Tat activator available and the first LRA that targets an HIV protein, and induces strong HIV production by latent cell lines and latent cells from people living with HIV-1.
P. Tong, Laetitia Marty, Nawel Chekrit et al.
· bioRxiv · 0 citations